CTI BioPharma Cash Flow - Quarterly (NASDAQ:CTIC)

Add to My Stocks
$1.91 $0.03 (1.6%) CTIC stock closing price Sep 19, 2018 (Closing)

For analyzing any company like CTI BioPharma from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about CTI BioPharma profits and CTI BioPharma debt. CTI BioPharma saw a cash impact of $64.17M from the issuance of CTIC shares. The cash flow statement helps in the CTI BioPharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. The cash from operating activities for CTI BioPharma is $ 2018 Q2, which saw a decrease from previous quarter.

View and download details of CTI BioPharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities1.76M--6.17M-6.77M3.4M9.32M-8.57M2.33M-7.23M1.05M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-1.78M-6.99M4M2.73M1.71M-15.98M-18.68M-25.06M-27.33M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.03M-0.03M-0.04M----0.13M-0.13M-0.1M-0.02M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-27.44M---------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares64.17M64.58M42.66M42.66M43.03M--0.31M---
Issuance (Repayment) of Debt Securities---3.57M-4.58M-3.9M-1.93M-5.45M-3.57M-1.76M-
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.08M--0.11M-0.09M-0.07M-0.03M-1.6M-0.6M-0.59M-0.24M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--0.71M-0.42M-0.41M-0.27M-0.04M--0.15M-0.11M-0.2M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year43.22M44M128.18M70.93M71.63M50.43M47.05M22.64M37.81M10.07M
Cash & Equivalents at Year End65.37M104.63M43.21M52.8M74.74M33.28M44M61.59M76.7M104.64M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The CTI BioPharma stock price history and CTI BioPharma stock comparison chart inevitably reflect its cash flow situation.

  • CTI BioPharma has cash of $65.37M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the CTI BioPharma stock price.
  • CTI BioPharma decreased its cash from operating activities to $-15.11M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-27.48M for CTIC stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $64.09M for CTI BioPharma.

Key Financial Ratios For CTI BioPharma Cash Flow

Quarterly Cash Flow Statements For CTI BioPharma Corp Peers

Incyte cash flow, MOLECULAR TEMPL cash flow, RAFAEL HOLDINGS cash flow, Teva Pharmaceutical cash flow